Business
Why Oxford’s Covid-19 vaccine could do more for the world than other shots – CNN
In the days since Oxford University and AstraZeneca unveiled the results of the partnership’s Phase 3 Covid-19 vaccine trials, a growing number of questions have…
London (CNN)In the days since Oxford University and AstraZeneca unveiled the results of the partnership’s Phase 3 Covid-19 vaccine trials, a growing number of questions have emerged.
The stated 70% average efficacy was significantly lower than the 94.5% to 95% reported by the other two leading candidates, Moderna and Pfizer.
Yet this vaccine could still prove to be more valuable for the world than the other two in the coming months. If the questions over its results are answered and it receives…
